Aminothiazole inhibitors of HCV RNA polymerase.

Bioorg Med Chem Lett

NeoGenesis Pharmaceuticals Inc., Department of Chemistry, 840 Memorial Drive, Cambridge, MA 02139, USA.

Published: January 2005

Aminothiazole-based inhibitors designed for HCV polymerase display low micromolar potencies in biochemical assays. These compounds show a stringent preference for a cyclohexyl hydrophobe at the 2-amino position. The composition of these compounds suggests that they may be interacting at a recently discovered allosteric site on the polymerase.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.10.024DOI Listing

Publication Analysis

Top Keywords

aminothiazole inhibitors
4
inhibitors hcv
4
hcv rna
4
rna polymerase
4
polymerase aminothiazole-based
4
aminothiazole-based inhibitors
4
inhibitors designed
4
designed hcv
4
hcv polymerase
4
polymerase display
4

Similar Publications

Article Synopsis
  • Acute lung injury (ALI) has a high mortality rate of 30-40% with no effective treatment currently available.
  • Research suggests that targeting inflammatory factors could be a potential therapeutic strategy for ALI.
  • In this study, a cinnamic acid derivative (compound 22) was found to inhibit IL-6 release and reduce lung injury symptoms in a mouse model, highlighting its potential as a new drug candidate for ALI.*
View Article and Find Full Text PDF

Nootkatone, a sesquiterpenoid widely used in the food and cosmetics industries, exhibits diverse biological activities and pharmaceutical prospects. Modification of nootkatone to create new derivatives with desirable activities has attracted significant attention. For this purpose, cytochrome P450 monooxygenases (P450 or CYP) are attractive candidates due to their ability to perform regio- and stereoselective hydroxylation at allylic C-H bonds.

View Article and Find Full Text PDF

In this study, thiazole derivatives containing sulphonamide, amide, and phenyl amino groups were synthesized to protect the free amino groups of 5-methyl-4-phenyl-2-aminothiazole and 4-phenyl-2-aminothiazole. Halogenated reactions of N-protected thiazole derivatives have been investigated. LCMS, FT-IR, H NMR, and C NMR spectroscopy techniques were used to elucidate the structures of the synthesized compounds.

View Article and Find Full Text PDF

Discovering New Metallo-Deubiquitinase CSN5 Inhibitors by a Non-Catalytic Activity Assay Platform.

J Med Chem

August 2024

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

COP9 signalosome catalytic subunit CSN5 plays a key role in tumorigenesis and tumor immunity, showing potential as an anticancer target. Currently, only a few CSN5 inhibitors have been reported, at least partially, due to the challenges in establishing assays for CSN5 deubiquitinase activity. Here, we present the establishment and validation of a simple and reliable non-catalytic activity assay platform for identifying CSN5 inhibitors utilizing a new fluorescent probe, , that exhibits enhanced fluorescence and fluorescence polarization features upon binding to CSN5.

View Article and Find Full Text PDF

A computational study was performed to investigate the dynamics of aqueous electrolytes containing organic corrosion inhibitors near electrified interfaces by using the constant-charge model in classical molecular dynamics simulations. The results showed that when inhibitors form films at the interface, the surface charge of the electrode causes displacement of the molecules, referred to as electroporation. The hydrophobicity of the inhibitor molecules affects both the stability of the films and their recovery time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!